Results after multivisceral resections of locally advanced colorectal cancers: An analysis on clinical and pathological t4 tumors

MakaleAçık Erişim
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Background: Locally advanced colorectal cancers are best treated with multivisceral resections. The aim of this study is to evaluate early and late results after multivisceral resections.Methods: All patients operated for primary colorectal cancer between 2001 and 2010 were -reviewed. These were compared within the patients underwent single organ and multivisceral resections: demographics, tumor and procedure related parameters, perioperative results, early oncological outcomes and 5-year survival.Results: A total of 354 patients (59.6 ± 13.8 years old, 210 [59.3%] males) were abstracted. Ninety (25.4%) patients underwent multivisceral resections for clinical T4 tumors and en-bloc R0 resection was achieved in 82 (91.1%). Only 31 (34.4% and 8.8% of clinical T4 and all cancers, respectively) cases had actual adjacent organ invasions (pT4). Males (20%) had lower risk for locally advanced tumors than females (33.3%) (p < 0.05). PT4 cancers were more common, if the clinical T4 tumor is located in the colon (48.8% vs 21.3%; p < 0.01). Laparoscopy was seldom initiated and the risk of conversion was higher in clinical T4 tumors (p < 0.05). The rates of sphincter-saving procedures were not different. Operation time, bleeding and transfusion requirements increased when multivisceral resections were necessitated (p < 0.05), but hospital stay, complications and 30-day mortality rates were similar. The 5-year survival rates were identical (p > 0.05).Conclusions: Clinical T4 tumors are not rare and more common in women. An actual invasion (pT4) may be observed in one third of all clinical T4 tumors, and more frequent in colon cancers. An en-bloc, R0, multivisceral resection may be achieved in most cases. Multivisceral resections do not alter the rates of sphincter-saving procedures, morbidity and 30-day mortality; do not worsen survival but increase operation time, intraoperative bleeding and perioperative transfusion requirements.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/15367Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1186/1477-7819-10-39Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGezen, Cem
dc.contributor.authorKement, Metin
dc.contributor.authorAltuntas, Yunus E.
dc.contributor.authorOkkabaz, Nuri
dc.contributor.authorSeker, Mesut
dc.contributor.authorVural, Selahattin
dc.contributor.authorGumus, Mahmut
dc.contributor.authorOncel, Mustafa
dc.date.accessioned2026-10-22T10:23:55.507752878Z
dc.date.available2026-10-22T10:23:55.507752878Z
dc.date.issued2012
dc.description.abstractBackground: Locally advanced colorectal cancers are best treated with multivisceral resections. The aim of this study is to evaluate early and late results after multivisceral resections.Methods: All patients operated for primary colorectal cancer between 2001 and 2010 were -reviewed. These were compared within the patients underwent single organ and multivisceral resections: demographics, tumor and procedure related parameters, perioperative results, early oncological outcomes and 5-year survival.Results: A total of 354 patients (59.6 ± 13.8 years old, 210 [59.3%] males) were abstracted. Ninety (25.4%) patients underwent multivisceral resections for clinical T4 tumors and en-bloc R0 resection was achieved in 82 (91.1%). Only 31 (34.4% and 8.8% of clinical T4 and all cancers, respectively) cases had actual adjacent organ invasions (pT4). Males (20%) had lower risk for locally advanced tumors than females (33.3%) (p < 0.05). PT4 cancers were more common, if the clinical T4 tumor is located in the colon (48.8% vs 21.3%; p < 0.01). Laparoscopy was seldom initiated and the risk of conversion was higher in clinical T4 tumors (p < 0.05). The rates of sphincter-saving procedures were not different. Operation time, bleeding and transfusion requirements increased when multivisceral resections were necessitated (p < 0.05), but hospital stay, complications and 30-day mortality rates were similar. The 5-year survival rates were identical (p > 0.05).Conclusions: Clinical T4 tumors are not rare and more common in women. An actual invasion (pT4) may be observed in one third of all clinical T4 tumors, and more frequent in colon cancers. An en-bloc, R0, multivisceral resection may be achieved in most cases. Multivisceral resections do not alter the rates of sphincter-saving procedures, morbidity and 30-day mortality; do not worsen survival but increase operation time, intraoperative bleeding and perioperative transfusion requirements.
dc.identifier.articlenumber39
dc.identifier.doi10.1186/1477-7819-10-39
dc.identifier.issn1477-7819
dc.identifier.pmid22336589
dc.identifier.scopus2-s2.0-84857010253
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/15367
dc.identifier.volume10
dc.identifier.wosWOS:000301671000003
dc.language.isoen
dc.publisherBIOMED CENTRAL LTD
dc.relation.ispartofWorld Journal of Surgical Oncology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectColorectal cancer
dc.subjectLocally advanced colorectal cancer
dc.subjectMorbidity and mortality
dc.subjectMultivisceral resection
dc.subjectPT4 tumor
dc.subjectSurvival
dc.subject.classificationOncology
dc.subject.classificationSurgery
dc.subject.otherAdenocarcinoma
dc.subject.otherColorectal Neoplasms
dc.subject.otherFemale
dc.subject.otherFollow-Up Studies
dc.subject.otherHumans
dc.subject.otherLymphatic Metastasis
dc.subject.otherMale
dc.subject.otherMiddle Aged
dc.subject.otherNeoplasm Recurrence, Local
dc.subject.otherNeoplasm Staging
dc.subject.otherPostoperative Complications
dc.subject.otherPrognosis
dc.subject.otherProspective Studies
dc.subject.otherSurvival Rate
dc.subject.otherViscera
dc.subject.otheradult
dc.subject.otheradvanced cancer
dc.subject.otherarticle
dc.subject.otherbladder
dc.subject.otherblood transfusion
dc.subject.othercancer invasion
dc.subject.othercancer mortality
dc.subject.othercancer staging
dc.subject.othercancer surgery
dc.subject.othercancer survival
dc.subject.otherchemoradiotherapy
dc.subject.othercolorectal cancer
dc.subject.otherheart failure
dc.subject.otherhemicolectomy
dc.subject.otherhistopathology
dc.subject.otherhospitalization
dc.subject.otherhuman
dc.subject.otherlung embolism
dc.subject.otherlung infection
dc.subject.otherlymph node metastasis
dc.subject.othermajor clinical study
dc.subject.othermorbidity
dc.subject.otheroperation duration
dc.subject.otherovary
dc.subject.otherperioperative period
dc.subject.otherpneumonia
dc.subject.otherproctocolectomy
dc.subject.othersepsis
dc.subject.othersmall intestine
dc.subject.othersphincter
dc.subject.othertreatment outcome
dc.subject.othertumor localization
dc.subject.otherureter
dc.subject.othercolorectal tumor
dc.subject.otherfollow up
dc.subject.othermetastasis
dc.subject.othermortality
dc.subject.otherpathology
dc.subject.otherpostoperative complication
dc.subject.otherprospective study
dc.subject.othertumor recurrence
dc.titleResults after multivisceral resections of locally advanced colorectal cancers: An analysis on clinical and pathological t4 tumors
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex85
rdl.citation.scopus74
rdl.citation.wos64
rdl.oa.statusgold
rdl.oa.urlhttps://wjso.biomedcentral.com/counter/pdf/10.1186/1477-7819-10-39
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)